title: Interleukin-22 serum levels are a negative prognostic indicator in patients with hepatocellular carcinoma.
authors.affiliation: Medizinische Klinik 1, Schwerpunkt Gastroenterologie und Hepatologie, Klinikum der Goethe-Universität Frankfurt, Frankfurt/Main, Germany.
authors.forename: Oliver
authors.initials: O
authors.lastname: Waidmann
authors.forename: Bernd
authors.initials: B
authors.lastname: Kronenberger
authors.forename: Patrick
authors.initials: P
authors.lastname: Scheiermann
authors.forename: Verena
authors.initials: V
authors.lastname: Köberle
authors.forename: Heiko
authors.initials: H
authors.lastname: Mühl
authors.forename: Albrecht
authors.initials: A
authors.lastname: Piiper
mesh_terms: D000818:Animals; D006528:Carcinoma, Hepatocellular / Q000209:etiology*; D005260:Female; D006801:Humans; D007378:Interleukins / Q000502:physiology*; D008113:Liver Neoplasms / Q000209:etiology*; D008297:Male; D050796:STAT3 Transcription Factor / Q000502:physiology*
chemical_list: D007378:Interleukins; D050796:STAT3 Transcription Factor